222 related articles for article (PubMed ID: 29298130)
1. Eradicating HPV-Associated Cancer Through Immunization: A Glass Half Full….
Frazer IH
Viral Immunol; 2018 Mar; 31(2):80-85. PubMed ID: 29298130
[TBL] [Abstract][Full Text] [Related]
2. A prophylactic quadrivalent vaccine for the prevention of infection and disease related to HPV-6, -11, -16 and -18.
Goldstone SE; Vuocolo S
Expert Rev Vaccines; 2012 Apr; 11(4):395-406. PubMed ID: 22551023
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive control of human papillomavirus infections and related diseases.
Bosch FX; Broker TR; Forman D; Moscicki AB; Gillison ML; Doorbar J; Stern PL; Stanley M; Arbyn M; Poljak M; Cuzick J; Castle PE; Schiller JT; Markowitz LE; Fisher WA; Canfell K; Denny LA; Franco EL; Steben M; Kane MA; Schiffman M; Meijer CJ; Sankaranarayanan R; Castellsagué X; Kim JJ; Brotons M; Alemany L; Albero G; Diaz M; de Sanjosé S;
Vaccine; 2013 Dec; 31 Suppl 5():F1-31. PubMed ID: 24331745
[TBL] [Abstract][Full Text] [Related]
4. The potential impact of prophylactic human papillomavirus vaccination on oropharyngeal cancer.
Guo T; Eisele DW; Fakhry C
Cancer; 2016 Aug; 122(15):2313-23. PubMed ID: 27152637
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive control of human papillomavirus infections and related diseases.
Bosch FX; Broker TR; Forman D; Moscicki AB; Gillison ML; Doorbar J; Stern PL; Stanley M; Arbyn M; Poljak M; Cuzick J; Castle PE; Schiller JT; Markowitz LE; Fisher WA; Canfell K; Denny LA; Franco EL; Steben M; Kane MA; Schiffman M; Meijer CJ; Sankaranarayanan R; Castellsagué X; Kim JJ; Brotons M; Alemany L; Albero G; Diaz M; de Sanjosé S;
Vaccine; 2013 Nov; 31 Suppl 8(0 8):I1-31. PubMed ID: 24229716
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of HPV vaccination in the context of high cervical cancer incidence and low screening coverage.
Võrno T; Lutsar K; Uusküla A; Padrik L; Raud T; Reile R; Nahkur O; Kiivet RA
Vaccine; 2017 Nov; 35(46):6329-6335. PubMed ID: 28899625
[TBL] [Abstract][Full Text] [Related]
7. [Papillomavirus, could we speak about cancer and prevention?].
Pernot S; Pavie J; Péré H; Menard M; Hurel S; Cochand-Priollet B; Bats AS; Badoual C
Bull Cancer; 2018 Feb; 105(2):137-139. PubMed ID: 29373106
[No Abstract] [Full Text] [Related]
8. 9-Valent human papillomavirus vaccine: a review of the clinical development program.
Luxembourg A; Moeller E
Expert Rev Vaccines; 2017 Nov; 16(11):1119-1139. PubMed ID: 28956458
[TBL] [Abstract][Full Text] [Related]
9. Toward using National Cancer Surveillance data for preventing and controlling cervical and other human papillomavirus-associated cancers in the US.
Saraiya M; Ahmed F; White M; Lawson H; Unger ER; Eheman C
Cancer; 2008 Nov; 113(10 Suppl):2837-40. PubMed ID: 18980202
[No Abstract] [Full Text] [Related]
10. EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease.
Arbyn M; de Sanjosé S; Saraiya M; Sideri M; Palefsky J; Lacey C; Gillison M; Bruni L; Ronco G; Wentzensen N; Brotherton J; Qiao YL; Denny L; Bornstein J; Abramowitz L; Giuliano A; Tommasino M; Monsonego J
Int J Cancer; 2012 Nov; 131(9):1969-82. PubMed ID: 22623137
[TBL] [Abstract][Full Text] [Related]
11. Human Papillomavirus and Associated Cancers: A Review.
Jensen JE; Becker GL; Jackson JB; Rysavy MB
Viruses; 2024 Apr; 16(5):. PubMed ID: 38793561
[TBL] [Abstract][Full Text] [Related]
12. [Human Papillomavirus: screening of cervical and anal cancers].
Pache B; Jacot-Guillarmod M; Hübner M; Mathevet P
Rev Med Suisse; 2022 Oct; 18(800):1950-1955. PubMed ID: 36259700
[TBL] [Abstract][Full Text] [Related]
13. Papillomavirus vaccine for women, and for men?
Hidalgo Tenorio C
Med Clin (Barc); 2019 Apr; 152(7):264-265. PubMed ID: 30591274
[No Abstract] [Full Text] [Related]
14. Cost-effectiveness of the prophylactic HPV vaccine: an application to the Netherlands taking non-cervical cancers and cross-protection into account.
Luttjeboer J; Westra TA; Wilschut JC; Nijman HW; Daemen T; Postma MJ
Vaccine; 2013 Aug; 31(37):3922-7. PubMed ID: 23806241
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology and burden of HPV-related disease.
Serrano B; Brotons M; Bosch FX; Bruni L
Best Pract Res Clin Obstet Gynaecol; 2018 Feb; 47():14-26. PubMed ID: 29037457
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology of HPV Related Malignancies.
Scott-Wittenborn N; Fakhry C
Semin Radiat Oncol; 2021 Oct; 31(4):286-296. PubMed ID: 34455984
[TBL] [Abstract][Full Text] [Related]
17. Reduced dose human papillomavirus vaccination: an update of the current state-of-the-art.
Toh ZQ; Licciardi PV; Fong J; Garland SM; Tabrizi SN; Russell FM; Mulholland EK
Vaccine; 2015 Sep; 33(39):5042-50. PubMed ID: 26271829
[TBL] [Abstract][Full Text] [Related]
18. Beyond cervical cancer: burden of other HPV-related cancers among men and women.
Chaturvedi AK
J Adolesc Health; 2010 Apr; 46(4 Suppl):S20-6. PubMed ID: 20307840
[TBL] [Abstract][Full Text] [Related]
19. [HPV: Carcinogenic implications and preventive measures].
Bernichon E; Espenel S; Méry B; Trone JC; Rehalia-Blanchard A; He YM; Rancoule C; Magné N
Presse Med; 2019; 48(7-8 Pt 1):756-766. PubMed ID: 31307878
[TBL] [Abstract][Full Text] [Related]
20. [The disease burden of human papillomavirus in men is substantial and can potentially be prevented].
Kiellberg Larsen H; Kofoed K; Sand C
Ugeskr Laeger; 2013 Feb; 175(6):349-53. PubMed ID: 23402241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
